| Company Name: |
Energy Chemical |
| Tel: |
400-0056266 |
| Email: |
marketing1@energy-chemical.com |
|
| | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone Basic information |
| Product Name: | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone | | Synonyms: | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone;JWH-073 4-Hydroxybutyl;JWH073-4-Hydroxybutyl metabolite;Methanone, [1-(4-hydroxybutyl)-1H-indol-3-yl]-1-naphthalenyl-;JWH-073 N-(4-hydroxybutyl) metabolite, 1mg/ml in Methanol;JWH-073 N-(4-hydroxybutyl) metabolite, 0.1mg/ml in Methanol | | CAS: | 335161-14-3 | | MF: | C23H21NO2 | | MW: | 343.42 | | EINECS: | | | Product Categories: | | | Mol File: | 335161-14-3.mol | ![[1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone Structure](CAS/20180601/GIF/335161-14-3.gif) |
| | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone Chemical Properties |
| Boiling point | 578.0±30.0 °C(Predicted) | | density | 1.16±0.1 g/cm3(Predicted) | | solubility | DMF: 30 mg/ml; DMF:PBS (pH 7.2) (1:9): 0.1 mg/ml; DMSO: 30 mg/ml; Ethanol: 0.5 mg/ml | | form | A crystalline solid | | pka | 15.13±0.10(Predicted) |
| | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone Usage And Synthesis |
| Description | JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.1 JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) metabolite is expected to be a major urinary metabolite of JWH 073, characterized by monohydroxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.2,3 In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.3 | | Uses | JWH-073 (Indole-d5) 4-Hydroxybutyl is labelled JWH-073 4-Hydroxybutyl (J211275), a urinary metabolite of JWH-073 (B693550) which acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. | | Definition | ChEBI: JWH 073 N-(4-hydroxybutyl) metabolite is an indolecarboxamide. | | References | 1. Aung, M.M., Griffin, G., Huffman, J.W., et al. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding Drug Alcohol Depend. 60(2),133-140(2000). 2. Zhang, Q., Ma, P., Cole, R.B., et al. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS Anal. Bioanal. Chem. 386(5),1345-1355(2006). 3. Sobolevsky, T., Prasolov, I., and Rodchenkov, G. Detection of JWH-018 metabolites in smoking mixture post-administration urine Forensic Sci. Int. 200(1-3),141-147(2010). |
| | [1-(4-hydroxybutyl)indol-3-yl]-naphthalen-1-ylmethanone Preparation Products And Raw materials |
|